Domain Therapeutics is perceived as one of OSE Immunotherapeutics's biggest rivals. Domain Therapeutics was founded in 2008, and is headquartered in Strasbourg, Other. Like OSE Immunotherapeutics, Domain Therapeutics also competes in the Biotechnology space. Domain Therapeutics generates $1.5M less revenue vs. OSE Immunotherapeutics.
Cellectis is a top competitor of OSE Immunotherapeutics. Cellectis is a Public company that was founded in 1999 in Paris, Île-de-France. Like OSE Immunotherapeutics, Cellectis also works within the Biotechnology sector. Compared to OSE Immunotherapeutics, Cellectis has 154 more employees.